PHARM FINAL EXAM VERSION # 3
CANCER, ONCOLOGY
Q6. An immunocompromised cancer patient has developed cryptococcal meningitis and been admitted
to the intensive care unit for treatment with amphotericin B. How should the nurse most safely
administer this drug? Answer: Infuse the drug over 2 to 4 hours into a central line using an infusion
pump. 1 out of 1 point.
Q23. A patient will soon begin targeted therapy as a component of her treatment plan for chronic
leukemia. The nurse is conducting health education about this new aspect of the patient's drug regimen
and the patient has asked about the potential side effects of treatment. How should the nurse best
respond? Answer: "Both classes of drugs have adverse effects, but targeted therapies tend to have less
of an effect on healthy body cells." 1 out of 1 point.
Q29. A Nurse Practitioner is caring for a 46-year-old female patient who is taking paclitaxel for ovarian
cancer. Two or three days after the infusion of the drug, the nurse must closely monitor for which of the
following? Answer: Neurotoxicity. 1 out of 1 point.
Q30. A Nurse Practitioner is assessing a patient who has chronic lymphoblastic myelogenous leukemia.
The treatment plan includes hydroxyurea (Hydrea). The nurse will assess the patient for which of the
following? Answer: Leukopenia. 1 out of 1 point.
Q46. Mr. Singh is a 66-year-old man who is receiving chemotherapy for the treatment of lung cancer
that has metastasized to his liver. In an effort, to prevent infection, Mr. Singh has been prescribed
filgrastim (Neupogen). Which of the nurse's following assessment questions most directly addresses a
common adverse effect of filgrastim? Answer: "Do you feel like you're having any pain in your bones?"
1 out of 1 point.
Q55. A 62-year-old patient taking tamoxifen exhibits increased bone and tumor pain along with a local
disease flare. The nurse interprets this as an indication of which of the following? Answer: The tumor
responding to treatment. 1 out of 1 point.
Q71. A Nurse Practitioner educator who coordinates the staff education on an oncology unit is
conducting an in-service on targeted therapies. What potential benefit of targeted therapies should the
nurse highlight in this education session? Answer: Targeted therapies have the potential to damage
cancerous cells while leaving normal body cells less affected. 1 out of 1 point.
Q75. A patient with chronic heart failure has begun treatment with epoetin alfa, which she will receive in
her own home from a home health nurse. The nurse should teach the patient to supplement this
treatment with a diet that is high in - Answer: iron-rich foods such as beans and leafy green vegetables. 1
out of 1 point.
Q78. A nurse practitioner has been assigned to a 55-year-old woman who has a malignant brain
tumor. The patient is receiving her first dose of carmustine. It will be critical for the nurse to observe
for which of the following? Answer: Respiratory difficulty. 1 out of 1 point.
This study source was downloaded by 100000852681095 from CourseHero.com on 09-28-2022 08:15:28 GMT -05:00
https://www.coursehero.com/file/102986188/Pharm-Cancer-Oncologydocx/
CANCER, ONCOLOGY
Q6. An immunocompromised cancer patient has developed cryptococcal meningitis and been admitted
to the intensive care unit for treatment with amphotericin B. How should the nurse most safely
administer this drug? Answer: Infuse the drug over 2 to 4 hours into a central line using an infusion
pump. 1 out of 1 point.
Q23. A patient will soon begin targeted therapy as a component of her treatment plan for chronic
leukemia. The nurse is conducting health education about this new aspect of the patient's drug regimen
and the patient has asked about the potential side effects of treatment. How should the nurse best
respond? Answer: "Both classes of drugs have adverse effects, but targeted therapies tend to have less
of an effect on healthy body cells." 1 out of 1 point.
Q29. A Nurse Practitioner is caring for a 46-year-old female patient who is taking paclitaxel for ovarian
cancer. Two or three days after the infusion of the drug, the nurse must closely monitor for which of the
following? Answer: Neurotoxicity. 1 out of 1 point.
Q30. A Nurse Practitioner is assessing a patient who has chronic lymphoblastic myelogenous leukemia.
The treatment plan includes hydroxyurea (Hydrea). The nurse will assess the patient for which of the
following? Answer: Leukopenia. 1 out of 1 point.
Q46. Mr. Singh is a 66-year-old man who is receiving chemotherapy for the treatment of lung cancer
that has metastasized to his liver. In an effort, to prevent infection, Mr. Singh has been prescribed
filgrastim (Neupogen). Which of the nurse's following assessment questions most directly addresses a
common adverse effect of filgrastim? Answer: "Do you feel like you're having any pain in your bones?"
1 out of 1 point.
Q55. A 62-year-old patient taking tamoxifen exhibits increased bone and tumor pain along with a local
disease flare. The nurse interprets this as an indication of which of the following? Answer: The tumor
responding to treatment. 1 out of 1 point.
Q71. A Nurse Practitioner educator who coordinates the staff education on an oncology unit is
conducting an in-service on targeted therapies. What potential benefit of targeted therapies should the
nurse highlight in this education session? Answer: Targeted therapies have the potential to damage
cancerous cells while leaving normal body cells less affected. 1 out of 1 point.
Q75. A patient with chronic heart failure has begun treatment with epoetin alfa, which she will receive in
her own home from a home health nurse. The nurse should teach the patient to supplement this
treatment with a diet that is high in - Answer: iron-rich foods such as beans and leafy green vegetables. 1
out of 1 point.
Q78. A nurse practitioner has been assigned to a 55-year-old woman who has a malignant brain
tumor. The patient is receiving her first dose of carmustine. It will be critical for the nurse to observe
for which of the following? Answer: Respiratory difficulty. 1 out of 1 point.
This study source was downloaded by 100000852681095 from CourseHero.com on 09-28-2022 08:15:28 GMT -05:00
https://www.coursehero.com/file/102986188/Pharm-Cancer-Oncologydocx/
